In the last trading session, 0.99 million Regenxbio Inc (NASDAQ:RGNX) shares changed hands as the company’s beta touched 1.08. With the company’s per share price at $9.79 changed hands at $0.9 or 10.12% during last session, the market valuation stood at $491.07M. RGNX’s last price was a discount, traded about -65.99% off its 52-week high of $16.25. The share price had its 52-week low at $5.03, which suggests the last value was 48.62% up since then.
Analysts gave the Regenxbio Inc (RGNX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.38. If we narrow down to specifics, the data shows that 0 out of 6 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended RGNX as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight.
Regenxbio Inc (NASDAQ:RGNX) trade information
Instantly RGNX was in green as seen at the end of in last trading. With action 22.84%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 26.65%, with the 5-day performance at 22.84% in the green. However, in the 30-day time frame, Regenxbio Inc (NASDAQ:RGNX) is 64.81% up.
The consensus price target for the stock as assigned by Wall Street analysts is 27, meaning bulls need an upside of 63.74% from its current market value. According to analyst projections, RGNX’s forecast low is 24 with 30 as the target high. To hit the forecast high, the stock’s price needs a -206.44% plunge from its current level, while the stock would need to soar -145.15% for it to hit the projected low.
Regenxbio Inc (RGNX) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -12.18%. The 2025 estimates are for Regenxbio Inc earnings to increase by 93.96%, but the outlook for the next 5-year period is at 25.78% per year.
Regenxbio Inc (NASDAQ:RGNX)’s Major holders
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 10.1061% or 5.11 million shares worth $59.83 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were JPMorgan Trust II-JPMorgan Small Cap Growth Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. With 1.99 shares estimated at $19.49 million under it, the former controlled 3.97% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.79% of the shares, roughly 1.4 shares worth around $13.71 million.
